l-carnitine and the heart Carnitine metabolism in hypertensive failure L-Carnitine Supplementation in the Diabetic

C., Parat, M-O., et al

However, this group may represent an interesting, intermediate clinical phenotype between archetypal Lyme disease and PTLD, as these types of presentations may occur before the onset of late Lyme arthritis, during which time objective manifestations may be transient ( Finally, given the lack of an available biomarker, there will always be a subset of patients with missed diagnoses of other diseases and conditions with similar symptoms, who initially seek evaluation for CLD with non-specific symptoms (90, 91)

10.1038/ismej.2013.237 ISME J

2k and Supplementary Fig

Text (406) 812-5779 to learn more or book